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Abstract
The case of a 64-year-old male patient who presented with a bulky osseous tumor metastasis from
renal cell carcinoma is reported. The metastatic lesion extended from the acetabulum of the left iliac
bone into the iliosacral joint.
Treatment plan included selective arterial embolization followed by transdermal radiofrequency
ablation, followed by consolidation irradiation. This sequence resulted in considerable necrosis of the
bulk of the tumor and creation of a large tissue deficit, which healed over the period of several
months despite anti-angiogenetic systematic treatment. The patient remains in good state of health,
20 months after the procedure. This case illustrates the usefulness of the embolization-ablation
sequence in controlling large osseus metastasis.
Introduction
Renal cancer is a relatively uncommon malignancy which
is however diagnosed with increasing frequency [1]. It
presents several challenges to the treating physician
because of its resistance to conventional anticancer
treatments and its relative sensitivity to immunological
or targeted therapies. Metastatic renal cell carcinoma has
been an area of important medical advances recently, as it
has been shown that it is responsive to antiangiogenic
therapy. As a result of the improved outcomes thus
achieved, the median survival of patients with metastatic
disease is reported to approach 2 years in recent trials.
Nevertheless, patients may experience significant morbid-
ity and overall impairment of their quality of life. Bone is a
common site of metastasis which is often symptomatic
and debilitating. Besides systematic treatments, the man-
agement of bone metastasis may include localized
modalities, more commonly external beam irradiation.
The success of this method is often limited as renal cell
carcinoma is known to be relatively radioresistant [2].
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carcinoma include local embolization [3-5] or ablation
methods. Embolization involves catheterization of the
feeding artery of the tumor and embolization with or
without instillation of anticancer agents. Embolization has
been used to treat primary renal cell carcinoma when
resection is not possible, with considerable success. It has
occasionally been used to treat metastatic disease as well.
Radiofrequency ablation [6] is another localized approach
whereby thermal tumor necrosis is achieved, usually via
transdermal route. Limitations include large tumor size,
accessibility of the tumor and sensitivity of adjacent
structures.
The combination of embolization and radiofrequency
ablation has not been adequately studied in the metastatic
setting [7]. It offers the advantage of ablating an already
injured and hypoxic cancerous mass, therefore enhancing
perhaps the anticancer effect. We hereby report a case of a
patient with a bulky osseous tumor metastasis from renal
cell carcinoma, successfully managed with a pre-planned
sequence of embolization followed by transdermal radio-
frequency ablation.
Case presentation
A 64-year-old Greek male patient underwent a radical
nephrectomy for a stage 2, grade 3, renal cell carcinoma in
September 2001. Five years later, he presented with left hip
pain and he was eventually diagnosed with biopsy proven
relapsed disease. Imaging with CT scans and bone scan
revealed a prominent bulky metastatic lesion extending
fromtheacetabulumoftheleft iliacboneintotheiliosacral
joint, a metastatic lesion of the second left rib, as well as
several metastatic pulmonary nodules (Figures 1a, b). He
was started on anti-angiogenetic TKI agent sorafenib and
biphosphonates.
After a year of treatment, in October 2007, a necrotic
ulceration appeared on the left flank area, proven by CT to
be an extension of the increasing metastatic left iliac focus,
which measured 8 cm in maximum diameter, associated
with increasing pain. The lesion was considered too large
to be controlled with irradiation. The patient underwent
an arterial embolization of the metastasis using a femoral
artery approach (Figure 2). One week later, the same mass
was treated by radiofrequency ablation (RFA) (Figure 3).
The procedure was well tolerated overall and led to
significant pain reduction (Figure 4). However, the
ulceration rapidly enlarged and evolved into a crater-like
deficit of the skin and subcutaneous tissue 5 cm deep and
of 5 cm diameter (Figure 5a). It was decided to be
managed conservatively with frequent local wound care.
Antiangiogenic treatment was suspended for a period of a
month to allow for wound healing. However, during this
time the pain recurred and a follow up CT showed
evidence of extension of the large lesion medially towards
the spinal canal; the bulk of the lesion was necrotic and
a large tissue deficit was documented. The patient received
external beam irradiation with symptomatic control
(4750 cGy in 19 sessions) followed by initiation of
sunitinib and biphosphonates. The patient continued
improving,regainedambulation,andhisdiseaseelsewhere
remained stable for over 16 months. His necrotic ulcer
has shrunk considerably to less than 0.5 cm in diameter
(Figure 5b, c). Because of intolerance to sunitinib, after
4 months of treatment, he was switched to bevacizumab.
The patient currently, as of October 2008, remains in good
state of health, with slowly progressing pulmonary nodes.
Figure 1. Pre-therapy CT images. (A) Axial T2-weighed image of the pelvis: shows a large lobulated mass with intermediate
signal intensity. (B) Post contrast T1W Fat Sat image: shows intense enhancement of the mass.
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Cases Journal 2009, 2:6484 http://casesjournal.com/casesjournal/article/view/6484Figure 2. (A) Anteroposterior view of aortogram demonstrates a prominent tumoral blush. The feeding arteries of the lesion
originated from both 4th lumbar and left internal iliac artery (arrows). (B) Selective catheterization of lumbar artery (left) and left
internal iliac artery (right). (C) Follow-up angiography after embolization shows no residual tumoral blush.
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Bulky bony metastasis of the axial skeleton of a relative
radioresistant tumor such as renal cell carcinoma is usually
a problematic medical situation associated with significant
morbidity. In the case of our patient the comorbidity was
exacerbated by the presence of skin infiltration and
ulceration caused by direct contiguous tumor invasion.
A conventional approach would have been to treat with
external beam irradiation and analgesics. Such an
approach would lead to local failure soon, given the
tumor bulk. The sequence of embolization followed by
radiofrequency ablation caused extensive necrosis of the
tumor bulk and creation of a large tissue deficit, which was
at first considered of ominous nature, but as it appears
heralded a favourable outcome. The significant tumor
reduction thus achieved may have resulted in the increased
efficacy of the subsequent therapies provided, namely
external beam irradiation and further antiangiogenetic
therapy. Of note, excellent wound healing with secondary
intent proceeded over the subsequent year, without
complications and in spite of antiangiogenetic therapy.
It is conceivable however that the administration of
Figure 3. Unenhanced CT scans obtained during ablation show the large exophytic ileac mass (A, B). The radio frequency
needle inserted into the mass under CT guidance through posterior approach.
Figure 4. Follow-up CT scan images 3 months post procedure show a large tissue deficit corresponded to ablated tissue.
Note the air within cavitary lesion.
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although without apparent untoward effects.
Therapeutic embolization of osseous metastases has been
previously reported in small number of patients with a
variety of tumors [3,8]. This procedure has even been
reported to result in a rapid resolution of neurological
symptoms if they were present [4]. In a report of five
patients with renal cell carcinoma the majority of patients
experienced significant relief of pain and improvement of
their overall clinical condition which lasted for several
months [5]. In the case of our patient, it was believed that
selective arterial embolization might have been inade-
quate to control the bulky tumor mass, not only because
of its size, but also because of its resistance to pharma-
ceutical antiangiogenic manipulations. Therefore, the
treatment plan included immediate post-embolization
radiofrequency ablation (RFA). This technique is usually
performed in patients with soft tissue metastases, mainly
of the liver. In renal cell cancer RFA has been applied as
an alternative to surgery for the definitive treatment of
primary tumors [9]. For the purpose of treating painful
osseous metastases it has occasionally been used in
combination with osteoplasty, again with considerable
success [9,10]. To our knowledge, the combination of
arterial embolization followed by RFA has only been
reported in two cases of non metastatic renal cell
carcinoma for the treatment of the primary tumor when
resection was not possible [7,9]. Despite the immediate
beneficial result, the location of the mass in the proximity
of the spinal canal raised the concern of possible under-
treatment of the medial part of the tumor. For that reason,
external beam irradiation was added, at a point when the
patient complained of increasing pain, without clear
radiographic evidence of tumor progression. It is note-
worthy that our complex therapeutic intervention resulted
in the creation of a very large tumor deficit, which did not
interfere with the patient’s quality of life and gradually
healed with secondary intent.
In conclusion, our case illustrates the usefulness of the
sequence of localized treatment for the management of
Figure 5. Post therapy MR follow up images (A, B, C) 10 months post procedure show shrinkage of the mass and
the cavitation as well and hypointense area corresponded to ablated tissue.
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approach should be entertained in selected patients as it
can yield long lasting favourable outcomes.
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